Time course of intestinal barrier function injury in a sodium taurocholate-induced severe acute pancreatitis in rat model

Journal of Digestive Diseases

Volumn 15, Issue 7, 2014, Pages 386-393

  Liang, Hong Yin ^a   Chen, Tao ^a   Wang, Tao ^a   Huang, Zhu ^a   Yan, Hong Tao ^a   Tang, Li Jun ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Acute necrotizing pancreatitis; Intestinal barrier function; Rats; Sodium taurocholate

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); ENDOTOXIN; LACTATE DEHYDROGENASE; TAUROCHOLIC ACID; AMYLASE;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HISTOPATHOLOGY; INTESTINAL BARRIER FUNCTION INJURY; INTESTINE FUNCTION DISORDER; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; LACTATE DEHYDROGENASE BLOOD LEVEL; NONHUMAN; PANCREAS DUCT; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; SEVERE ACUTE PANCREATITIS; TIME PERCEPTION; ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; ILEUM; INTESTINE ABSORPTION; METABOLISM; PANCREATITIS; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SURVIVAL;

ACUTE DISEASE; AMYLASES; ANIMALS; BACTERIAL TRANSLOCATION; DISEASE MODELS, ANIMAL; ILEUM; INTESTINAL ABSORPTION; PANCREATITIS; PERMEABILITY; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; TAUROCHOLIC ACID;

EID: 84903883902     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12148     Document Type: Article

References (24)

1. Morel DR, Frossard JL, Cikirikcioglu B, Tapponnier M, Pastor CM. Time course of lung injury in rat acute pancreatitis. Intensive Care Med 2006; 32: 1872-1880.
2. Lankisch PG, Lerch MM. Pharmacological prevention and treatment of acute pancreatitis: where are we now? Dig Dis 2006; 24: 148-159.
3. Zhang XP, Zhang J, Song QL, Chen HQ. Mechanism of acute pancreatitis complicated with injury of intestinal mucosa barrier. J Zhejiang Univ Sci B 2007; 8: 888-895.
4. Gurleyik E, Coskun O, Ustundag N, Ozturk E. Prostaglandin E1 maintains structural integrity of intestinal mucosa and prevents bacterial translocation during experimental obstructive jaundice. J Invest Surg 2006; 19: 283-289.
5. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 2013; 70: 631-659.
6. Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil 2012; 24: 503-512.
7. Chen X, Zhao HX, Fu XS, Li CP, Zhong XL. Glucagonlike peptide 2 protects intestinal barrier in severe acute pancreatitis through regulating intestinal epithelial cell proliferation and apoptosis. Pancreas 2012; 41: 1080-1085.
8. Zhang JX, Dang SC, Yin K, Jiang DL. Protective effect of clodronate-containing liposomes on intestinal mucosal injury in rats with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 2011; 10: 544-551.
9. Zhang X, Chen L, Luo L etal. Study of the protective effects of dexamethasone on ileum mucosa injury in rats with severe acute pancreatitis. Pancreas 2008; 37: e74-82.
10. Nakajima T, Ueda T, Takeyama Y etal. Protective effects of vascular endothelial growth factor on intestinal epithelial apoptosis and bacterial translocation in experimental severe acute pancreatitis. Pancreas 2007; 34: 410-416.
11. Schmidt J, Rattner DW, Lewandrowski K etal. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992; 215: 44-56.
12. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970; 101: 478-483.
13. Chiu CJ, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. II. The protective effect of intraluminal glucose as energy substrate. Arch Surg 1970; 101: 484-488.
14. Kahl S, Mayer JM. Update on experimental acute pancreatitis. Minerva Gastroenterol Dietol 2012; 58: 355-363.
15. Lerch MM, Gorelick FS. Models of acute and chronic pancreatitis. Gastroenterology 2013; 144: 1180-1193.
16. Mayerle J, Dummer A, Sendler M etal. Differential roles of inflammatory cells in pancreatitis. J Gastroenterol Hepatol 2012; 27 Suppl 2: 47-51.
17. Wan MH, Huang W, Latawiec D etal. Review of experimental animal models of biliary acute pancreatitis and recent advances in basic research. HPB (Oxford) 2012; 14: 73-81.
18. Jha RK, Yong MQ, Chen SH. The protective effect of resveratrol on the intestinal mucosal barrier in rats with severe acute pancreatitis. Med Sci Monit 2008; 14: BR14-19.
19. Wang X, Wang B, Wu J, Wang G. Beneficial effects of growth hormone on bacterial translocation during the course of acute necrotizing pancreatitis in rats. Pancreas 2001; 23: 148-156.
20. Luan ZG, Zhang H, Ma XC, Zhang C, Guo RX. Role of high-mobility group box 1 protein in the pathogenesis of intestinal barrier injury in rats with severe acute pancreatitis. Pancreas 2010; 39: 216-223.
21. Qin HL, Su ZD, Hu LG, Ding ZX, Lin QT. Effect of early intrajejunal nutrition on pancreatic pathological features and gut barrier function in dogs with acute pancreatitis. Clin Nutr 2002; 21: 469-473.
22. Zhang Z, Wang Y, Dong M, Cui J, Rong D, Dong Q. Oxymatrine ameliorates L-arginine-induced acute pancreatitis in rats. Inflammation 2012; 35: 605-613.
23. Hartwig W, Schimmel E, Hackert T etal. A novel animal model of severe pancreatitis in mice and its differences to the rat. Surgery 2008; 144: 394-403.
24. Clarke LL. A guide to Ussing chamber studies of mouse intestine. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1151-1166.